Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma

BACKGROUND: Induction chemotherapy (IC) can alleviate locoregionally advanced nasopharyngeal carcinoma (LA-NPC), but effectiveness differs between patients, toxicity is problematic, and effective blood-based IC efficacy predictors are lacking. Here, we aimed to identify biomarkers for early identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shan-Qiang, Pan, Su-Ming, Lai, Shu-Zhen, Situ, Hui-Jing, Liu, Jun, Dai, Wen-Jie, Liang, Si-Xian, Zhou, Li-Qing, Lu, Qi-Qi, Ke, Pei-Feng, Zhang, Fan, Chen, Hai-Bin, Li, Ji-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279567/
https://www.ncbi.nlm.nih.gov/pubmed/35847896
http://dx.doi.org/10.3389/fonc.2022.889516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279567/
https://www.ncbi.nlm.nih.gov/pubmed/35847896
http://dx.doi.org/10.3389/fonc.2022.889516

Ejemplares similares